# Wuhan Landing Medical High-Tech Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/wuhan-landing-medical-high-tech-co

- Industry: Healthcare Specialists
- Headquarters: Wuhan, China
- Website: www.landing-med.com
- Total disclosed funding: $50M
- Latest round: Series D (Nov 10, 2021)
- Investors on record: 7

## About

Founded in 2000 and based in Wuhan, China, Wuhan Landing Medical High-Tech Co., Ltd. is a medical device company that focuses on developing innovative early cancer detection products and technologies. At present, the company have 12 subsidiaries and has established 5 large-scale artificial intelligence laboratories and 67 small and medium-sized artificial intelligence laboratories.

The company is mainly engaged in artificial intelligence cancer cell diagnosis research, production, sales, clinical screening services. The company self developed products include artificial intelligence cervical cancer screening system and artificial intelligence bone marrow cell (leukemia) diagnosis system.

The company plans to create an AI tumor diagnosis cloud with AliHealth.

## Funding rounds

- Series D, Nov 10, 2021, $50M — Ether Capital, AliHealth
- Series C, Oct 24, 2018 — Bank of China Group Investment, China Merchants Capital
- Series B, May 4, 2017 — Fenyi Capital, Sangel Capital, Daotong Investment

## Investors

- Fenyi Capital — Series B
- Sangel Capital (https://capitalatlas.ai/funds/sangel-capital) — Series B
- Daotong Investment — Series B
- Bank of China Group Investment — Series C
- China Merchants Capital (https://capitalatlas.ai/funds/china-merchants-capital) — Series C
- Ether Capital (https://capitalatlas.ai/funds/ether-capital) — Series D
- AliHealth — Series D